Daroda C, Galluzzo C, Porzia R, Riva E, Giovannini M
Minerva Med. 1981 Feb 28;72(7):363-6.
The therapeutic effectiveness of a new antiinflammatory-expectorant drug, guacetisal (Broncaspin) has been compared with that of a well known mucolytic, bromexine, already available for therapy, in the paediatric suspension formula. The study was carried out on 26 children in the 1st Paediatrics clinic of Milan University. The children were suffering from inflammation of the respiratory apparatus. It is concluded that the new drug possesses greated clinical effectiveness.
一种新型消炎祛痰药瓜西他尔（溴环己胺醇）已制成儿科用悬浮液配方，其治疗效果已与一种已用于治疗的知名黏液溶解剂溴己新进行了比较。该研究在米兰大学第一儿科诊所的26名儿童中进行。这些儿童患有呼吸器官炎症。结论是这种新药具有更高的临床疗效。
